Cargando…

Copper and zinc concentrations in the breast milk of mothers undergoing treatment for Wilson’s disease: a prospective study

OBJECTIVE: To evaluate the concentrations of copper and zinc in the breast milk of mothers undergoing treatment for Wilson’s disease (WD) and clarify whether they can safely breast feed their infants. DESIGN: This was an observational and prospective study in an individual-based case series. SETTING...

Descripción completa

Detalles Bibliográficos
Autores principales: Kodama, Hiroko, Anan, Yasumi, Izumi, Yoichi, Sato, Yasuhiro, Ogra, Yasumitsu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8212407/
https://www.ncbi.nlm.nih.gov/pubmed/34222678
http://dx.doi.org/10.1136/bmjpo-2020-000948
_version_ 1783709633662156800
author Kodama, Hiroko
Anan, Yasumi
Izumi, Yoichi
Sato, Yasuhiro
Ogra, Yasumitsu
author_facet Kodama, Hiroko
Anan, Yasumi
Izumi, Yoichi
Sato, Yasuhiro
Ogra, Yasumitsu
author_sort Kodama, Hiroko
collection PubMed
description OBJECTIVE: To evaluate the concentrations of copper and zinc in the breast milk of mothers undergoing treatment for Wilson’s disease (WD) and clarify whether they can safely breast feed their infants. DESIGN: This was an observational and prospective study in an individual-based case series. SETTING: Breast milk samples were collected from participants across Japan from 2007 to 2018 at the Department of Pediatrics, Teikyo University in Tokyo. This was a primary-care level study. Clinical data were collected from the participants’ physicians. PATIENTS: Eighteen Japanese mothers with WD who were treated with trientine, penicillamine or zinc, and 25 healthy mothers as controls, were enrolled. MAIN OUTCOME MEASURES: Whey exacted from the milk was used to evaluate the distribution of copper by high-performance liquid chromatography-inductively coupled plasma mass spectrometry. Copper and zinc concentrations in the breast milk samples were analysed by atomic absorption spectrometry. RESULTS: Copper distribution was normal in the breast milk of mothers with WD treated with trientine, penicillamine or zinc. No peak was detected for trientine-bound or penicillamine-bound copper. The mean copper concentrations in the mature breast milk of patients treated with trientine, penicillamine and zinc were 29.6, 26 and 38 µg/dL, respectively, and were within the normal range compared with the value in healthy controls (33 µg/dL). Likewise, mean zinc concentrations were normal in the mature breast milk of patients treated with trientine and penicillamine (153 and 134 µg/dL, respectively vs 160 µg/dL in healthy controls). Zinc concentrations in the breast milk of mothers treated with zinc were significantly higher than those in control milk. All infants were born normally, breast fed by mothers undergoing treatment and exhibited normal development. CONCLUSIONS: Our results suggest that mothers with WD can safely breast feed their infants, even if they are receiving treatment for WD.
format Online
Article
Text
id pubmed-8212407
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher BMJ Publishing Group
record_format MEDLINE/PubMed
spelling pubmed-82124072021-07-01 Copper and zinc concentrations in the breast milk of mothers undergoing treatment for Wilson’s disease: a prospective study Kodama, Hiroko Anan, Yasumi Izumi, Yoichi Sato, Yasuhiro Ogra, Yasumitsu BMJ Paediatr Open Nutrition OBJECTIVE: To evaluate the concentrations of copper and zinc in the breast milk of mothers undergoing treatment for Wilson’s disease (WD) and clarify whether they can safely breast feed their infants. DESIGN: This was an observational and prospective study in an individual-based case series. SETTING: Breast milk samples were collected from participants across Japan from 2007 to 2018 at the Department of Pediatrics, Teikyo University in Tokyo. This was a primary-care level study. Clinical data were collected from the participants’ physicians. PATIENTS: Eighteen Japanese mothers with WD who were treated with trientine, penicillamine or zinc, and 25 healthy mothers as controls, were enrolled. MAIN OUTCOME MEASURES: Whey exacted from the milk was used to evaluate the distribution of copper by high-performance liquid chromatography-inductively coupled plasma mass spectrometry. Copper and zinc concentrations in the breast milk samples were analysed by atomic absorption spectrometry. RESULTS: Copper distribution was normal in the breast milk of mothers with WD treated with trientine, penicillamine or zinc. No peak was detected for trientine-bound or penicillamine-bound copper. The mean copper concentrations in the mature breast milk of patients treated with trientine, penicillamine and zinc were 29.6, 26 and 38 µg/dL, respectively, and were within the normal range compared with the value in healthy controls (33 µg/dL). Likewise, mean zinc concentrations were normal in the mature breast milk of patients treated with trientine and penicillamine (153 and 134 µg/dL, respectively vs 160 µg/dL in healthy controls). Zinc concentrations in the breast milk of mothers treated with zinc were significantly higher than those in control milk. All infants were born normally, breast fed by mothers undergoing treatment and exhibited normal development. CONCLUSIONS: Our results suggest that mothers with WD can safely breast feed their infants, even if they are receiving treatment for WD. BMJ Publishing Group 2021-06-17 /pmc/articles/PMC8212407/ /pubmed/34222678 http://dx.doi.org/10.1136/bmjpo-2020-000948 Text en © Author(s) (or their employer(s)) 2021. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. https://creativecommons.org/licenses/by-nc/4.0/This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/ (https://creativecommons.org/licenses/by-nc/4.0/) .
spellingShingle Nutrition
Kodama, Hiroko
Anan, Yasumi
Izumi, Yoichi
Sato, Yasuhiro
Ogra, Yasumitsu
Copper and zinc concentrations in the breast milk of mothers undergoing treatment for Wilson’s disease: a prospective study
title Copper and zinc concentrations in the breast milk of mothers undergoing treatment for Wilson’s disease: a prospective study
title_full Copper and zinc concentrations in the breast milk of mothers undergoing treatment for Wilson’s disease: a prospective study
title_fullStr Copper and zinc concentrations in the breast milk of mothers undergoing treatment for Wilson’s disease: a prospective study
title_full_unstemmed Copper and zinc concentrations in the breast milk of mothers undergoing treatment for Wilson’s disease: a prospective study
title_short Copper and zinc concentrations in the breast milk of mothers undergoing treatment for Wilson’s disease: a prospective study
title_sort copper and zinc concentrations in the breast milk of mothers undergoing treatment for wilson’s disease: a prospective study
topic Nutrition
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8212407/
https://www.ncbi.nlm.nih.gov/pubmed/34222678
http://dx.doi.org/10.1136/bmjpo-2020-000948
work_keys_str_mv AT kodamahiroko copperandzincconcentrationsinthebreastmilkofmothersundergoingtreatmentforwilsonsdiseaseaprospectivestudy
AT ananyasumi copperandzincconcentrationsinthebreastmilkofmothersundergoingtreatmentforwilsonsdiseaseaprospectivestudy
AT izumiyoichi copperandzincconcentrationsinthebreastmilkofmothersundergoingtreatmentforwilsonsdiseaseaprospectivestudy
AT satoyasuhiro copperandzincconcentrationsinthebreastmilkofmothersundergoingtreatmentforwilsonsdiseaseaprospectivestudy
AT ograyasumitsu copperandzincconcentrationsinthebreastmilkofmothersundergoingtreatmentforwilsonsdiseaseaprospectivestudy